Fig 1. ROS production was increased in different cell types of patients with β Thalassemia intermedia.

Analysis of DCFDA fluorescence intensity, corresponding to the level of ROS production in erythroid, mononuclear and neutrophils cells. The results are expressed as mean (±SEM) fluorescence intensity (MFI) emitted by the analyzed cells of control and BTI patients. Statistical difference: (*) p < 0.05 and (***) p < 0.001.